Abstract 4357: The lactate receptor Gpr81 on non-cancer cells promotes an immunosuppressive phenotype in the tumor microenvironment
Authors: Brown Timothy , Ramachandran Sabarish , Offermanns Stefan , Ganapathy Vadivel 
Published: August 2019

Abstract
Cancer cells display a unique phenomenon in which, even in the presence of oxygen, cells switch from oxidative phosphorylation to glycolysis as the primary source of ATP with consequent production of lactic acid. This phenomenon, called the Warburg Effect, is a hallmark of cancer. Lactic acid has long been considered as the necessary end product of this metabolic switch, where lactic acid is effluxed out of tumor cells to prevent intracellular acidification. Recent evidence however suggests that lactate and the excess protons in the tumor microenvironment play an active role in tumor growth. In particular, lactate has been shown to function as an agonist for GPR81, a G-protein-coupled receptor expressed on the surface of tumor cells. This autocrine signaling of lactate promotes tumor growth and metastasis, as well as angiogenesis and immune evasion. The present study assesses whether tumor cell-derived lactate has any paracrine role via its receptor in non-cancer cells present in the tumor microenvironment. We generated MMTV-PyMT-Tg mice, a spontaneous model for breast cancer, on Gpr81+/+ and Gpr81-/- backgrounds. The absence of Gpr81 reduced the mammary tumor incidence, delayed mammary tumor progression, and reduced lung metastasis. These data demonstrate the essential role of GPR81 in breast cancer growth and metastasis, but does not differentiate between Gpr81 in tumor cells versus Gpr81 in the tumor microenvironment. We then used the syngeneic transplant of the mouse mammary tumor cell line AT-3 into the mammary fat pads of wild type and Gpr81-/- mice to assess the involvement of Gpr81 in the microenvironment. AT-3 cells are negative for Gpr81, and therefore our model limits Gpr81 expression to non-tumor cells in the host mouse. We found the growth of transplanted tumor cells was significantly reduced in Gpr81-/- mice than in wild type mice. Preliminary RNA-sequencing transcriptome analysis of AT-3 tumors suggest an immunosuppressive function of Gpr81, where tumors grown in a Gpr81-/- background have much stronger gene expression profiles in T-cell signaling pathways. Specifically, AT-3 tumors grown in Gpr81-/- host express significantly higher levels of genes that are specific for T cells and antigen-presenting cells such as MHC-II complex molecules, T-cell co-stimulatory molecules, and transmembrane CD8. It is well established that tumor-cell derived lactate promotes tumor growth in an autocrine manner via Gpr81 expressed on tumor cells; our studies extend the tumor-promoting role of lactate beyond this autocrine function to include paracrine signaling via Gpr81 expressed on immune cells and possibly other cell types in the tumor microenvironment.
Citation Format: Timothy Brown, Sabarish Ramachandran, Stefan Offermanns, Vadivel Ganapathy. The lactate receptor Gpr81 on non-cancer cells promotes an immunosuppressive phenotype in the tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4357.